IP Group, a British-based intellectual property business investing in technology companies, led a $269m funding round in Oxford Nanopore, a company developing and selling nanopore sequencing products. The round was joined by Temasek, Wellington Management, M&G Investments and Nikon. “The technology developed by Oxford Nanopore is used in a wide range of scientific research applications, including further biomedical sciences, to characterize pathogens in microbiology and public health. It is used by institutional investors in society. It’s an example of how it can play an important role in accelerating the growth of a more profitable company," Jack Daniels, M&G Investments Chief Investment Officer.